Maternal and neonatal effects of substance abuse during pregnancy: Our ten-year experience

Yonsei Medical Journal

Volumn 49, Issue 5, 2008, Pages 705-713

  Vucinovic, Mirjana ^a   Roje, Damir ^a   Vučinović, Zoran ^a   Capkun, Vesna ^a   Bucat, Marija ^a   Banović, Ivo ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Illicit drug; Neonatal outcome; Pregnancy outcome

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; DIAMORPHINE; ILLICIT DRUG; METHADONE;

APGAR SCORE; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG DEPENDENCE; EUROPE; FEMALE; GESTATIONAL AGE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ABUSE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL WELFARE; NEWBORN; NEWBORN CARE; NEWBORN MORTALITY; OBSTETRICS; OUTCOME ASSESSMENT; PERINATAL DEVELOPMENT; PERSONAL EXPERIENCE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; PRENATAL DRUG EXPOSURE; RISK FACTOR; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ADULT; APGAR SCORE; BIRTH WEIGHT; CROATIA; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; INCIDENCE; INFANT MORTALITY; INFANT, NEWBORN; MATERNAL EXPOSURE; METHADONE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME;

EID: 58149458875     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.5.705     Document Type: Article

References (38)

1. Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth 2003;15:382-94.
2. Oei J, Kei L. Management of the newborn infant affected by maternal opiates and other drugs of dependency. J Paediatr Child Health 2007;43:9-18.
3. Sakoman S. Care of pregnant women with opioid abuse and of their newborns. Gynaecol Perinatol Suppl 2006; 15:93-101.
4. Coleman PK, Reardon DC, Rue VM, Cougle J. A history of induced abortion in relation to substance use during subsequent pregnancies carried to term. Am J Obstet Gynecol 2002;187:1673-8.
5. Fabris C, Prandi G, Perathoner C, Soldi A. Neonatal drug addiction. Panminerva Med 1998;40:239-43.
6. Hulse GK, Milne E, English DR, Holman CD. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction 1998;93:1033-42.
7. Stone ML, Salerno LJ, Green M, Zelson C. Narcotic addiction in pregnancy. Am J Obstet Gynecol 1971;109: 716-23.
8. Ostrea EM, Chavez CJ. Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases. J Pediatr 1979;94:292-5.
9. Huestis MA, Choo RE. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int 2002;128:20-30.
10. Olofsson M, Buckley W, Anderson GE, Friis-Hansen B. Investigation of 89 children born by drug-dependent mothers. II. Follow-up 1-10 years after birth. Acta Paediatr Scand 1983;72:407-10.
11. Olofsson M, Buckley W, Andersen GE, Friis-Hansen B. Investigation of 89 children born by drug-dependent mothers. I. Neonatal course. Acta Paediatr Scand 1983; 72:403-6.
12. Rosen TS, Johnson HL. Children of methadone-maintained mothers: follow-up to 18 months of age. J Pediatr 1982;101:192-6.
13. Bell GL, Lau K. Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am 1995;42:261-81.
14. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975;2:141-58.
15. Roje D, Tadin I, Marušić J, Vulić N, Aračić M, Vučinović M, et al. Birth weights and birth lengths of newborns from the town of Split; the importance of developing own standards. Gynaecol Perinatol 2005;14: 69.
16. Roje D, Banovic I, Tadin I, Vucinovic M, Capkun V, Barisic A, et al. Gestational age-the most important factor of neonatal ponderal index. Yonsei Med J 2003; 45:273-80.
17. The patients rights law. Accessed May 19, 2007. Available from: URL: http://www.nn.hr/clanci/sluzbeno/2004.
18. Sakoman S. National strategy on drug abuse control in Republic of Croatia. Zagreb: Croatian Government Comitee for drug abuse control; 1995.
19. Sakoman S. Substance abuse in the Republic of Croatia and National Program for Drug Control. Croat Med J 2000;41:270-86.
20. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997;92: 1571-9.
21. Kandall SR, Albin S, Dreyer E, Comstock M, Lowinson J. Differential effects of heroin and methadone on birth weights. Addict Dis 1975;2:347-55.
22. Lam SK, To WK, Duthie SJ, Ma HK. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust N Z J Obstet Gynaecol 1992;32:216-21.
23. Connaughton JF, Reeser D, Schut J, Finnegan LP. Perinatal addiction: outcome and management. Am J Obstet Gynecol 1997;129:679-86.
24. HIV/AIDS in Europe: moving from death sentence to chronic disease management. In: Matic S, Lazarus JV, Donoghoe MC, editors. Copenhagen: WHO Regional Office for Europe; 2006.
25. Crofts N, Aitken CK, Kaldor JM. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust 1999;170:220-1.
26. Garland SM, Tabrizi S, Robinson P, Hughes C, Markman L, Devenish W, et al. Hepatitis C-role of perinatal transmission. Aust N Z J Obstet Gynaecol 1998;38:424-7.
27. Little BB, Snell LM, Klein VR, Gilstrap LC 3rd, Knoll KA, Breckenridge JD. Maternal and fetal effects of heroin addiction during pregnancy. J Reprod Med 1990;35:159-62
28. Thornton L, Clune M, Maguire R, Griffin E, O'Connor J. Narcotic addiction: the expectant mother and her baby. Ir Med J 1990;83:139-42.
29. Ellwood DA, Sutherland P, Kent C, O'Connor M. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust N Z J Obstet Gynaecol 1987; 27:92-8.
30. Stimmel B, Adamsons K. Narcotic dependency in pregnancy. Methadone maintenance compared to use of street drugs. JAMA 1976;235:1121-4.
31. Carrera JM, Devesa R, Serra B. Classification of intrauterine growth retardation. In: Kurjak A, editor. A textbook of perinatal medicine. London: Parthenon Publishing; 1998. p.1192-200.
32. Levy M, Spino M. Neonatal withdrawal syndrome: associated drugs and pharmacologic management. Pharmacotherapy 1993;13:202-11.
33. Carin I, Glass L, Parekh A, Solomon N, Steigman J, Wong S. Neonatal methadone withdrawal. Effect of two treatment regimens. Am J Dis Child 1983;137: 1166-9.
34. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 2006;26:15-7.
35. Kaltenbach K, Finnegan LP. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol 1986;8:353-5.
36. Langenfeld S, Birkenfeld L, Herkenrath P, Müller C, Hellmich M, Theisohn M. Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops. Drug Alcohol Depend 2005;77:31-6.
37. Velaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sánchez PJ. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics 2003;111:541-7.
38. Dashe JS, Sheffield JS, Olscher DA, Todd SJ, Jackson GL, Wendel GD. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002;100:1244-9.